Literature DB >> 30467372

Author Correction: Multiple sclerosis.

Massimo Filippi1,2, Amit Bar-Or3, Fredrik Piehl4,5,6, Paolo Preziosa7,8, Alessandra Solari9, Sandra Vukusic10, Maria A Rocca7,8.   

Abstract

In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.

Entities:  

Year:  2018        PMID： 30467372     DOI： 10.1038/s41572-018-0050-3

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN： 2056-676X            Impact factor:   52.329


  9 in total

1.  Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life.

Authors:  Zahra Salehi; Masoud Arabfard; Omid Sadatpour; Mina Ohadi
Journal:  Neurol Sci       Date:  2020-07-16       Impact factor: 3.307

Review 2.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

3.  Brain oxygen extraction fraction mapping in patients with multiple sclerosis.

Authors:  Junghun Cho; Thanh D Nguyen; Weiyuan Huang; Elizabeth M Sweeney; Xianfu Luo; Ilhami Kovanlikaya; Shun Zhang; Kelly M Gillen; Pascal Spincemaille; Ajay Gupta; Susan A Gauthier; Yi Wang
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-24       Impact factor: 6.960

Review 4.  Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen
Journal:  Biores Open Access       Date:  2020-03-31

Review 5.  Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease.

Authors:  Lindsey E Fox; Marissa C Locke; Deborah J Lenschow
Journal:  Front Immunol       Date:  2020-12-21       Impact factor: 7.561

6.  The Association of EBV and HHV-6 Viral Load with Different NK and CD8+ T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis.

Authors:  Zahra Salehi; Masoumeh Beheshti; Bizhan Nomanpour; Pardis Khosravani; Maryam Naseri; Mohammad Ali Sahraian; Maryam Izad
Journal:  Cell J       Date:  2021-11-23       Impact factor: 2.479

7.  RNA Sequencing of CD4+ T Cells in Relapsing-Remitting Multiple Sclerosis Patients at Relapse: Deciphering the Involvement of Novel genes and Pathways.

Authors:  Saeed Talebi; Samaneh Maleknia; Fahimeh Palizban; Zahra Salehi; Abdorreza Naser Moghadasi; Kaveh Kavousi; Mohammad Ali Sahraian; Maryam Izad
Journal:  J Mol Neurosci       Date:  2021-07-21       Impact factor: 3.444

8.  Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis.

Authors:  Alberto Gajofatto; Valeria Donisi; Isolde Martina Busch; Francesca Gobbin; Elena Butturini; Massimiliano Calabrese; Alessandra Carcereri de Prati; Paola Cesari; Lidia Del Piccolo; Massimo Donadelli; Paolo Fabene; Stefania Fochi; Macarena Gomez-Lira; Roberta Magliozzi; Giovanni Malerba; Raffaella Mariotti; Sofia Mariotto; Chiara Milanese; Maria Grazia Romanelli; Andrea Sbarbati; Federico Schena; Maria Angela Mazzi; Michela Rimondini
Journal:  BMJ Open       Date:  2019-08-02       Impact factor: 2.692

9.  Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis.

Authors:  Meng-Han Shen; Chau Yee Ng; Kuo-Hsuan Chang; Ching-Chi Chi
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.